Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Signal peptide, CUB domain and EGF-like domain-containing protein 2 (SCUBE2) is a multidomain, secreted, and membrane-associated protein comprising an N-terminal signal peptide, nine EGF-like repeats, a spacer region, three cysteine-rich motifs, and a C-terminal CUB domain[1][2][3][4][5]. SCUBE2 is broadly expressed in various tissues (heart, lung, testis, bone, vascular endothelium) and plays a key role as a mediator in Hedgehog signaling, especially in early developmental processes[2][3][6]. In cancer, SCUBE2 functions as a tumor suppressor—overexpression inhibits cell proliferation in breast, gastric, and colorectal cancer models, and low SCUBE2 expression is associated with poor prognosis[1][2][4]. At the molecular level, SCUBE2 modulates signaling pathways by antagonizing bone morphogenetic protein activity (via its CUB domain) and mediating calcium-dependent cell-cell adhesion (via EGF repeats, interacting with E-cadherin), thus inhibiting β-catenin pathway signaling[1][2]. SCUBE2 is also involved in osteoblast and chondrocyte differentiation, regulates angiogenesis through VEGFR2 interaction, and has been genetically linked to arteriovenous malformations and autism spectrum disorder[3]. Although not currently targeted by licensed drugs, its biological functions and disease associations make it a notable research target and diagnostic biomarker for oncological and developmental studies[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal peptide, CUB domain and EGF-like domain-containing protein 2 (SCUBE2).